A Subset of PD-1-Expressing CD56(bright) NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer

SIMPLE SUMMARY: In recent years, studies in cancer immunotherapy have focused on finding predictive response biomarkers to anticipate which patients will respond to each kind of treatment, optimizing treatment strategy and reducing toxicities and costs. Unfortunately, these studies are still limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Gascón-Ruiz, Marta, Ramírez-Labrada, Ariel, Lastra, Rodrigo, Martínez-Lostao, Luis, Paño-Pardo, J. Ramón, Sesma, Andrea, Zapata-García, María, Moratiel, Alba, Quílez, Elisa, Torres-Ramón, Irene, Yubero, Alfonso, Domingo, María Pilar, Esteban, Patricia, Gálvez, Eva M., Pardo, Julián, Isla, Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856517/
https://www.ncbi.nlm.nih.gov/pubmed/36672279
http://dx.doi.org/10.3390/cancers15020329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856517/
https://www.ncbi.nlm.nih.gov/pubmed/36672279
http://dx.doi.org/10.3390/cancers15020329

Ejemplares similares